PERSISTENCE OF TETANUS ANTITOXIN IN MAN FOLLOWING ACTIVE IMMUNIZATION

Human tetanus antitoxin.

Tetanus Antitoxin from Intraocular Transplants **

Evidence for antibody formation by various cells, tissues, and organs has come mainly from studies employing the following methods: (i) extracts of tissue cultures,'l (ii) cannulization of afferent and efferent lymph,"'X (iii) extracts of cells, tissues, and organs,"' (iv) extirpation of the spleen," and (v) roentgen-radiation of animals with lead-protected mobilized spleens.' Although the repo...

Antigen-Specific Antibody Response in Juvenile-Onset SLE Patients Following Routine Immunization with Tetanus Toxoid

Background: Infection is now the most common cause of morbidity in Systemic Lupus Erythematosus (SLE). There is lack of information regarding the specific antibody forma-tion in response to vaccines in young SLE patients. Objective: To determine the efficacy of anti-tetanus antibody response in young patients with SLE. Methods: Forty SLE pa-tients with mean age of 14.1 years (range: 7-21) and 6...

Tetanus Immunization *

Tetanus immunity produced in man by injections of tetanus toxoid is receiving an increasing amount of attention. That man responds to two or three injections of such toxoid-preferably alum-precipitated-with the production of antitoxin has been established firmly by a number of investigators during the past few years. Of the more recent work, that by Bergey and Etris,2 Bergey,' Jones and Moss,6 ...

Tetanus antitoxin titres in military personnel.

A study was made of the titres of tetanus antitoxin in the sera of 186 recruits and 886 serving personnel. All were found to have titres of more than 0.01 IU per ml, the titre regarded as sufficient to provide protection from tetanus. The percentage of recruits with tetanus antitoxin titres less than 0.1 IU per ml was significantly greater than the percentage of serving personnel with antitoxin...